Comparison of patient-reported outcome measures in multiple sclerosis

Acta Neurologica Scandinavica

Volumn 128, Issue 2, 2013, Pages 114-121

  Schaffler N ^a   Schonberg P ^a   Stephan, J ^a   Stellmann, J P ^a   Gold, S M ^a   Heesen, C ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Multiple sclerosis; Quality of life

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; QUALITY OF LIFE; SELF REPORT;

MULTIPLE SCLEROSIS; QUALITY OF LIFE;

ADULT; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; STATISTICS AS TOPIC;

EID: 84880153375     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12083     Document Type: Article

References (32)

1. Sharrack B, Hughes RA, Soudain S, Dunn G. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 1999;122(Pt 1):141-59.
2. Ebers GC, Heigenhauser L, Daumer M, Lederer C, Noseworthy JH. Disability as an outcome in MS clinical trials. Neurology 2008;71:624-31.
3. Sormani MP, Bonzano L, Roccatagliata L, Mancardi GL, Uccelli A, Bruzzi P. Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach. Neurology 2010;75:302-9.
4. Hobart J, Cano S. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess 2009;13:iii, ix-x, 1-177.
5. Hobart J, Kalkers N, Barkhof F, Uitdehaag B, Polman C, Thompson A. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite. Mult Scler 2004;10:41-6.
6. Hoogervorst ELJ, Eikelenboom MJ, Uitdehaag BMJ, Polman CH. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report. J Neurol Neurosurg Psychiatry 2003;74:439-42.
7. Pfaffenberger N, Gutweniger S, Kopp M et al. Impaired body image in patients with multiple sclerosis. Acta Neurol Scand 2011;124:165-70.
8. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patient reported outcomes: the example of health related quality of life - a european guidance document for the improved integration of health related quality of life assesment in the drug regulatory process. Drug Inf J 2002;36:209-37.
9. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001;124(Pt 5):962-73.
10. Gold SM, Heesen C, Schulz H et al. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler 2001;7:119-30.
11. Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L. Cognitive impairment in early-onset multiple sclerosis: pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol 1995;52:168.
12. Kraft GH, Johnson KL, Yorkston K et al. Setting the agenda for multiple sclerosis rehabilitation research. Mult Scler 2008;14:1292-7.
13. Heesen C, Böhm J, Reich C, Kasper J, Goebel M, Gold SM. Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler 2008;14:988-91.
14. Gold SM, Schulz H, Mönch A, Schulz K-H, Heesen C. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler 2003;9:404-10.
15. Gold SM, Schulz H, Stein H, Solf K, Schulz K-H, Heesen C. Responsiveness of patient-based and external rating scales in multiple sclerosis: head-to-head comparison in three clinical settings. J Neurol Sci 2010;290:102-6.
16. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
17. Cutter GR, Baier ML, Rudick RA et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122(Pt 5):871-82.
18. Rudick R, Antel J, Confavreux C et al. Clinical outcomes assessment in multiple sclerosis. Ann Neurol 1996;40:469-79.
19. Smith A. The symbol digit modalities test. Learn Disabil 1968;3:83-91.
20. Drake AS, Weinstock-Guttman B, Morrow SA, Hojnacki D, Munschauer FE, Benedict RHB. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler 2010;16:228-37.
21. Heesen C, Reich C, Borchers C, Gold SM. Patientenbasierte Scoringsysteme bei Multipler Sklerose-Untersuchung zur Validierung der United Kingdom Disability Scale (UNDS) und des Patient Generated Index (PGI). Neurol Rehabil 2007;13:24.
22. Koch M, Glazenborg A, Uyttenboogaart M, Mostert J, De Keyser J. Pharmacologic treatment of depression in multiple sclerosis (Review). Cochrane Database Syst Rev 2011:Art.No.: CD007295.
23. Benedict RHB, Duquin JA, Jurgensen S et al. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler 2008;14:940-6.
24. Mitchell AJ, Benito-León J, González J-MM, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 2005;4:556-66.
25. van der Linden FAH, Kragt JJ, Hobart JC et al. The size of the treatment effect: do patients and proxies agree? BMC Neurol 2009;9:12.
26. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales. J Neurol Neurosurg Psychiatry 2005;76:1539-43.
27. Hoogervorst E, Zwemmer J, Jelles B, Polman C, Uitdehaag B. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability. Mult Scler 2004;10:569-74.
28. Khan F, Pallant JF, Brand C, Kilpatrick TJ. Effectiveness of rehabilitation intervention in persons with multiple sclerosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry 2008;79:1230-5.
29. Giordano A, Pucci E, Naldi P et al. Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study. J Neurol Neurosurg Psychiatry 2009;80:1023-8.
30. Costelloe L, O'Rourke K, McGuigan C, Walsh C, Tubridy N, Hutchinson M. The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite. Mult Scler 2008;14:255-8.
31. Costelloe L, O'Rourke K, Kearney H et al. The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical). J Neurol Neurosurg Psychiatry 2007;78:841-4.
32. Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med 1999;48:1531-48.